This suggests that future strategies for managing and treating CF will need to be focused on correcting the underlying proteostasis/autophagy impairment, mainly via rescuing F508del-CFTR to the PM, which would simultaneously control the inflammatory-oxidative stress response in the airways of CF subjects. This evidence concerns the gene CFTR and cystic fibrosis.